REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026RESEARCHA Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [NCT06382155]RESEARCHMetabolic Effects of Angiotensin-(1-7) [NCT02646475]RESEARCHEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [NCT06651177]RESEARCHMulti-Site Trial of Tirzepatide for Smoking Cessation [NCT07602699]RESEARCHA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [NCT06897475]RESEARCHTranslational Health Research Into Vascular and Neurocognitive Effects of Weight Loss [NCT07592546]RESEARCHTirzepatide in the Treatment of Endometrial Cancer [NCT07605247]RESEARCHA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [NCT06635057]RESEARCHA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [NCT07165028]NEWSOorja, run by Acceleron veterans, launches to make new fibrosis drugsREGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026RESEARCHA Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [NCT06382155]RESEARCHMetabolic Effects of Angiotensin-(1-7) [NCT02646475]RESEARCHEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [NCT06651177]RESEARCHMulti-Site Trial of Tirzepatide for Smoking Cessation [NCT07602699]RESEARCHA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [NCT06897475]RESEARCHTranslational Health Research Into Vascular and Neurocognitive Effects of Weight Loss [NCT07592546]RESEARCHTirzepatide in the Treatment of Endometrial Cancer [NCT07605247]RESEARCHA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [NCT06635057]RESEARCHA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [NCT07165028]NEWSOorja, run by Acceleron veterans, launches to make new fibrosis drugs

For research purposes only. Full disclaimer →

Science & Research
5

DSIP for sleep optimization - my protocol

Darcy Hart·22 days ago
Just completed my first full cycle and the results exceeded my expectations in some areas while falling short in others. Detailed breakdown below.

Comments (8)

Chris GomezDEMO·2 months ago

Important safety note - anyone considering this should definitely get baseline blood work first. Cannot stress this enough.

0
Maple HowardDEMO·about 2 months ago

Important safety note - anyone considering this should definitely get baseline blood work first. Cannot stress this enough.

0
Bailey HowardDEMO·about 1 month ago

Important safety note - anyone considering this should definitely get baseline blood work first. Cannot stress this enough.

0
Arden DouglasDEMO·22 days ago

Important safety note - anyone considering this should definitely get baseline blood work first. Cannot stress this enough.

2
Jesse AshfordDEMO·21 days ago

Your results are interesting because most of the DSIP literature is actually from the 1980s-90s Soviet research. It is one of those peptides where the anecdotal community reports are actually ahead of the Western clinical data. What dose range are you using?

0
Blake AshfordDEMO·20 days ago

I tried DSIP for 6 weeks and the effect on sleep onset latency was dramatic - went from 30-40 minutes to under 10 minutes to fall asleep. But I did not see the deep sleep improvements some people report. Maybe my dose was too low at 50mcg.

0
Harper AllenDEMO·19 days ago

Did you compare this to other sleep-promoting compounds like glycine, magnesium threonate, or even prescription options? I am trying to figure out where DSIP fits in the hierarchy of sleep interventions for someone who has tried the basics.

0
Dale BanksDEMO·18 days ago

The areas where you fell short are just as valuable as the wins. Too many reports only highlight positives. What specifically did not meet expectations? Was it total sleep time, dream quality, next-day alertness?

0

Sign in to comment.